Joseph Morott

Dr. Joseph T. Morott is a highly qualified pharmaceutical sciences expert with nearly two decades of specialized experience in drug formulation, development, and regulatory compliance. He holds a Ph.D. in Pharmaceutical Sciences with an emphasis in Pharmaceutics from the University of Mississippi School of Pharmacy, where he graduated with a 3.8 GPA and received the Honors Convocation Graduate Achievement Award in Pharmaceutics. His doctoral research focused on hot melt extrusion technology and drug release mechanisms in polymeric matrices, establishing a strong foundation for his subsequent career in pharmaceutical development.

Dr. Morott's professional experience spans the entire drug development lifecycle, from early-stage research through NDA and ANDA filings and commercialization. His expertise encompasses controlled release systems, osmotic pump technology (OROS), hot-melt extrusion, abuse-deterrent formulations, and DEA-regulated controlled substances. Throughout his career at leading pharmaceutical organizations including Mylan Pharmaceuticals, Catalent Pharma Solutions, Balchem Corporation, and Pegasus Laboratories, he has served as a subject matter expert, resolved complex formulation challenges, and contributed to regulatory remediation efforts including 483 and Warning Letter responses.

What distinguishes Dr. Morott as an expert witness candidate is his unique combination of deep technical knowledge and exceptional communication skills, refined through a decade in television broadcasting prior to his pharmaceutical career and further developed as a Hot-Melt Extrusion instructor. He has consistently demonstrated the ability to translate complex scientific concepts into clear, accessible information for diverse audiences, including non-technical stakeholders, customers, and industry professionals. His experience in customer relations, cross-functional collaboration, and technical presentation, combined with his authoritative knowledge of pharmaceutical manufacturing, regulatory compliance, and drug delivery systems, positions him to provide credible, comprehensible expert testimony in pharmaceutical litigation matters.